Folate Analog Metabolic Inhibitor
43 drugs across 19 manufacturers|28 Generic,15 Brand
The Folate Analog Metabolic Inhibitor class contains 43 NDCs from 19 manufacturers (28 generic, 15 brand), at an average NADAC of $136.52 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
43
28G / 15B
Manufacturers
19
Avg $136.5235/unit
Avg 7d Change
+0.85%
Across 25 drugs with changes
7d Activity
of 43 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
19 manufacturers producing drugs in this therapeutic class(4 pricing outliers)
and 7 more manufacturers
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
Medexus Pharma Inc. manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
Methotrexate market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the Folate Analog Metabolic Inhibitor class?
The Folate Analog Metabolic Inhibitor class contains 43 NDCs from 19 manufacturers — 28 generic and 15 brand products.
What is the average price of Folate Analog Metabolic Inhibitor drugs?
The average NADAC for the Folate Analog Metabolic Inhibitor class is $136.5235 per unit across 43 NDCs.
Is generic cheaper than brand in the Folate Analog Metabolic Inhibitor class?
Among products priced per ML, the average generic NADAC in this class is $1.6585, versus $478.1794 for brand — brand products average about 288× the generic price.
Which manufacturers make Folate Analog Metabolic Inhibitor drugs?
19 manufacturers make drugs in the Folate Analog Metabolic Inhibitor class. Ranked by number of NDCs, the largest are Medexus Pharma Inc. (7), Hospira Inc. (5), Antares Pharma, Inc. (4), Accord Healthcare Inc. (4), Teva Women's Health, Inc. (3).
How has Folate Analog Metabolic Inhibitor pricing changed recently?
Over the past 7 days, 23 NDCs in this class rose and 2 fell, with a class-wide average change of +0.8%.